(R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)picolinonitrile

Catalog No. :
ACEUSN789
CAS No. :
1597428-07-3
Molecular Formula :
C16H12FN3O3
Molecular Weight :
313.29

IUPAC Name:(R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)picolinonitrile

(R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)picolinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)picolinonitrile
IUPAC Name(R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)picolinonitrile
Molecular FormulaC16H12FN3O3
Molecular Weight313.29
SMILESN#CC1=NC=C(C2=CC=C(N3C[C@H](CO)OC3=O)C=C2F)C=C1
InChI KeyIRNRTVCIXBMKKB-CYBMUJFWSA-N
Synonym(R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl) phenyl)picolinonitrile;Tedizolid Impurity 48;Torezolid-22;Tedizolid impurity 30/(R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl) phenyl)picolinonitrile;2-Pyridinecarbonitrile, 5-[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-3-oxazolidinyl]phenyl]-;Tedizolid impurity579;Terazolamide impurity 24
CAS No.1597428-07-3

Synthetic Route by SureRoute

1. ACEUSN789 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEUSN789 route product structure diagram
    ACEUSN7891597428-07-3
Inquiry

2. ACEUSN789 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRKVO360 route compound structure diagram
    ACRKVO3601011722-07-8 In Stock
  2. Plus
  3. ACFXKU514 route compound structure diagram
    ACFXKU514444335-16-4 In Stock
  4. Then
  5. ACEUSN789 route product structure diagram
    ACEUSN7891597428-07-3
Inquiry

Comments (0)